These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Ergometric, dynamographic and electromyographic aspects of myasthenia]. SCHERRER J; BOURGUIGNON A Pathol Biol; 1961 May; 9():1119-25. PubMed ID: 13747534 [No Abstract] [Full Text] [Related]
4. Motor end plate changes in myasthenia gravis. CHURCHILL-DAVIDSON HC Am J Phys Med; 1959 Aug; 38():159-62. PubMed ID: 13810230 [No Abstract] [Full Text] [Related]
5. Neuromuscular transmission in myasthenia gravis. CHURCHILL-DAVIDSON HC; RICHARDSON AT Am J Med; 1955 Nov; 19(5):691-2. PubMed ID: 13268465 [No Abstract] [Full Text] [Related]
6. Basic and clinical concepts in myasthenia gravis. SCHWAB RS Int J Neurol; 1961; 2():224-35. PubMed ID: 13909633 [No Abstract] [Full Text] [Related]
7. Alterations in muscle tension without similar changes in electrical activity in patients with myasthenia gravis. BOTELHO SY J Clin Invest; 1955 Sep; 34(9):1403-9. PubMed ID: 13252087 [No Abstract] [Full Text] [Related]
8. The effect of certain endocrine glands on myasthenia gravis. KANE CA Am J Med; 1955 Nov; 19(5):729-33. PubMed ID: 13268472 [No Abstract] [Full Text] [Related]
9. An electrophysiologic study of the neuromuscular junction in myasthenia gravis. DAHLBACK O; ELMQVIST D; JOHNS TR; RADNER S; THESLEFF S J Physiol; 1961 Apr; 156(2):336-43. PubMed ID: 13719322 [No Abstract] [Full Text] [Related]
10. Studies in myasthenia gravis. Evaluation of cardiac conduction. KORNFELD P; OSSERMAN KE J Mt Sinai Hosp N Y; 1962; 29():330-3. PubMed ID: 14458472 [No Abstract] [Full Text] [Related]
11. [The phenomena of facilitation and post-activation exhaustion in myasthenia gravis and its physiopathological significance]. DESMEDT JE Pathol Biol; 1961 May; 9():1149-56. PubMed ID: 13722198 [No Abstract] [Full Text] [Related]
12. Comparison of simultaneously recorded electrical and mechanical activity in myasthenia gravis patients and in partially curarized normal humans. BOTELHO SY Am J Med; 1955 Nov; 19(5):693-6. PubMed ID: 13268466 [No Abstract] [Full Text] [Related]
13. Alterations in neuromuscular transmission in myasthenia gravis as determined by studies of drug action. GROB D; JOHNS RJ; HARVEY AM Am J Med; 1955 Nov; 19(5):684-90. PubMed ID: 13268464 [No Abstract] [Full Text] [Related]
14. Studies in neuromuscular function. II. Effects of nerve stimulation in normal subjects and in patients with myasthenia gravis. GROB D; HARVEY AM; JOHNS RJ Bull Johns Hopkins Hosp; 1956 Sep; 99(3):125-35. PubMed ID: 13364528 [No Abstract] [Full Text] [Related]
15. [Electromyography of eye muscles in myasthenia gravis]. Tietze K; Glatzel W Psychiatr Neurol Med Psychol (Leipz); 1980 Feb; 32(2):111-5. PubMed ID: 7394081 [TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis. III. Lack of inhibitory action of fractionated thymus extracts. ZACKS SI Proc Soc Exp Biol Med; 1958 Dec; 99(3):574-5. PubMed ID: 13614427 [No Abstract] [Full Text] [Related]